TechCrunch Disrupt Battlefield 2023 winner, BioticsAI, announced on Monday that it has received FDA clearance for its AI ...

In a proof-of-concept study, researchers from the Keck School of Medicine of USC and the California Institute of Technology ...

Merge Labs has emerged from stealth with $252 million in funding from OpenAI and others. It aims to use ultrasound to read ...

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans is now offering histotripsy, a non ...

A new monthly clinic designed to help spot the early signs of liver disease will launch in Goole later this month. Specialist ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

In a technical note conducted as a part of ongoing research for liver disease prediction, detection, monitoring, and staging, the ultrasound-guided attenuation parameter (UGAP) technology maintained ...

The local Knights of Columbus Councils have helped the Sophia Women’s Center in Salem purchase a new ultrasound machine. Pictured from left, first row, Pat Morrisey, Tom Englert, Father James Lang, ...